3D Tissue Models

Pharmacology: Johnson & Johnson

Total Score People Score Events Score
5 5 5
Date Event Presentation Speakers
August 5, 2009 New Frontiers in Cancer Drug Development Translational Medicine: Predictive and Pharmacodynamic Biomarkers in Cancer Drug Development Nicholas C. Dracopoli
June 9, 2009 Inaugural The Expanding Impact of New Animal Models in Drug Safety Interlaboratory Evaluation of Genomic Signatures for Predicting Carcinogenicity in the Rat Michael McMillian
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty William N Hait
May 30, 2008 ASCO Annual'08 Meeting professional development-- Mid-Career Changes: Why, How, and When? William Hait
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) NEXT GENERATION HDAC INHIBITORS (10:35-12:40) Janine Arts
NEXT GENERATION HDAC INHIBITORS: JNJ-26481585 - A Novel “Second-generation” Oral Pan-Histone Deacetylase (HDAC) Inhibitor - Shows Broad-spectrum Preclinical Antitumoral Activity Against Solid and Haematological Malignancies (12:10-12:40) Janine Arts
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.